Boriani, Giuseppe
Laroche, Cécile
Diemberger, Igor
Popescu, Mircea Ioachim
Rasmussen, Lars Hvilsted
Petrescu, Lucian
Crijns, Harry J. G. M.
Tavazzi, Luigi
Maggioni, Aldo P.
Lip, Gregory Y. H.
Article History
Received: 11 February 2016
Accepted: 29 June 2016
First Online: 28 July 2016
Change Date: 22 February 2017
Change Type: Update
Change Details: A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has not been fixed in the paper.
Competing interests
: G.Boriani—received small speaker’s fees from Boehringer, Medtronic Inc and Boston Scientific. L.H.Rasmussen—speaker bureaus for Bayer, BMS/Pfizer, Janssen Pharmaceuticals, Takeda, Roche Diagnostics, and Boehringer Ingelheim. L.Tavazzi—consultant and Speakers bureau member for Servier; Committee Member for Servier, Medtronic, St Jude Medical, CVIE Therapeutics, Boston Scientific, Vifor Pharma, Cardiorentis. G.Y.H.Lip—consultant for Bayer, Medtronic, Sanofi, BMS/Pfizer, Daiichi-Sankyo, and Boehringer Ingelheim, and has been a speaker for Bayer, BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo and Medtronic. Other authors—none declared in relation to this manuscript.